Novo Nordisk rises 5.65% after raising its annual outlook
FROM THE WIRE · FINANCE.YAHOO.COM
This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO) gave investors a reason to buy Wednesday. The Danish drugmaker's U.S. depositary shares rose 5.65% to $42.46 at 10:35 a.m. ET on November 4 after it raised its annual outlook for adjusted sales and operating…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishGuidance raise from a major drugmaker, with a strong share reaction.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Novo Nordisk ADR rose 5.65% to $42.46.
- 02Third-quarter adjusted operating profit climbed 27% at constant exchange rates.
- 03Reported operating profit fell 9% after DKK8.7 billion in noncash impairments.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets